Used in cancer research, particularly in studies targeting the PI3K pathway, which is involved in cell growth and survival. Shows potential in treating solid tumors and hematological malignancies by inhibiting tumor cell proliferation and promoting apoptosis. Investigated in clinical trials for breast cancer, glioblastoma, and non-small cell lung cancer. Often studied in combination with other anticancer agents to overcome resistance and improve efficacy. Its ability to cross the blood-brain barrier makes it of interest in brain tumor research.